Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02127931 · ClinicalTrials.gov registry record · NA

Predictive Executive Functioning Models Using Interactive Tangible-Graphical Interface Devices in Adults

A NA study of Attention Deficit Hyperactivity Disorder, sponsored by CogCubed.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT02127931 is a NA study of Attention Deficit Hyperactivity Disorder that has completed, run by CogCubed. The registered enrollment target is 18 participants, below the 207-participant average among 88 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02127931, a NA study of Attention Deficit Hyperactivity Disorder, has completed, sponsored by CogCubed.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

Current diagnostic aids used in treating ADHD are currently expensive, time intensive, and provide little information about accessory movements in response to a stimulus. Tests such as the Conners' Rating Scale require subjective responses from parents and teachers, making coordination difficult. The computerized Conners' Continuous Performance Test (CPT) provides objective data in regards to inattention and impulsive patterns of response. However, it does not provide data regarding accessory movements such as restlessness, hyperactivity, and other inappropriate movements. If the subject taking the exam has a reading disorder, it will impair his or her ability to respond accurately and it will increase response time. The T.O.V.A. is another computer based test used as a diagnostic aid for ADHD, which uses a microswitch to record responses. It does utilize auditory and visual stimuli, which removes the reading level limitation. However, it is unable to measure to measure accessory movements that may be contributing to reaction time and errors of omission and commission. Because of these limitations, a new company called CogCubed has created a new game based on the Sifteo Cube (http://www.sifteo.com) platform. These new hands-on digitized cubes are unique, motion-sensitive wireless blocks that contain multiple sensors that can interact with one another. CogCubed is providing the data for this study. The game will be played in a 30 minute sessions by subjects aged 18 and over. Subjects recruited to play the game will be those with ADHD and those without, matched by gender. Those with comorbidities of developmental delay, mental retardation, psychosis, schizophrenia, bipolar disorder and substance use disorders will be excluded, as well as any physiological disability that affects upper limb movement and/or coordination. Informed consent will be obtained from participant prior to administering the game. The hypothesis is that by analyzing data generated from this new

Interventions

  • DEVICE Groundskeeper for ADHD group
  • DEVICE Groundskeeper for control group

Study Locations (1)

Minnesota

  • Macalester College - Saint Paul

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2014-03
Est. Completion 2016-12-01
Phase NA

Sponsor

CogCubed

3 total trials

What the Registry Record Tells You About NCT02127931

The ClinicalTrials.gov registry entry for NCT02127931 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 207-participant average among 88 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (91% lower). The listed sponsor is CogCubed, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Attention Deficit Hyperactivity Disorder appearing as the primary indexed condition, and to 2 interventions - of which Groundskeeper for ADHD group is the first listed.

NCT02127931 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT02127931 about?

NCT02127931 is a clinical study titled "Predictive Executive Functioning Models Using Interactive Tangible-Graphical Interface Devices in Adults". Current diagnostic aids used in treating ADHD are currently expensive, time intensive, and provide little information about accessory movements in response to a stimulus. Tests such as the Conners' Rating Scale require subjective responses from parents and teachers, making coordination difficult. T...

What is the current status of trial NCT02127931?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2014-03. Estimated completion is 2016-12-01.

What conditions does trial NCT02127931 study?

This clinical trial studies the following conditions: Attention Deficit Hyperactivity Disorder.

What interventions are being tested in trial NCT02127931?

The interventions under investigation include: Groundskeeper for ADHD group (DEVICE), Groundskeeper for control group (DEVICE).

Who is sponsoring clinical trial NCT02127931?

This trial is sponsored by CogCubed, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02127931 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Attention Deficit Hyperactivity Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.